医药-话题@MedSci

#医药#

1668篇内容 | 2734人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1410084, encodeId=946d141008420, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=今日，医药代表备案制正式施行, objectType=article, longId=204071, objectId=bf932040e188, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf932040e188, replyNumber=0, likeNumber=103, createdTime=2020-12-04, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf932040e188, moduleTitle=今日，医药代表备案制正式施行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf932040e188)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410083, encodeId=b3f91410083cf, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=殊途同归——中日医药代表新规比较, objectType=article, longId=204070, objectId=56a52040e0d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56a52040e0d6, replyNumber=0, likeNumber=76, createdTime=2020-12-04, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56a52040e0d6, moduleTitle=殊途同归——中日医药代表新规比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56a52040e0d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410082, encodeId=1db4141008225, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=北京市中医药条例通过禁止虚假、夸大宣传中医药, objectType=article, longId=204031, objectId=a12820403160, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a12820403160, replyNumber=0, likeNumber=86, createdTime=2020-12-03, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a12820403160, moduleTitle=北京市中医药条例通过禁止虚假、夸大宣传中医药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a12820403160)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410081, encodeId=44ee141008144, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=中国生物医药黄金时代已来，学术转化困境犹存, objectType=article, longId=203854, objectId=3cc220385402, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cc220385402, replyNumber=0, likeNumber=71, createdTime=2020-11-30, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cc220385402, moduleTitle=中国生物医药黄金时代已来，学术转化困境犹存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cc220385402)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410080, encodeId=f912141008057, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=和铂医药干眼症新药特那西普2期研究结果即将公布，效果良好, objectType=article, longId=203505, objectId=131620350518, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=131620350518, replyNumber=0, likeNumber=70, createdTime=2020-11-19, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=131620350518, moduleTitle=和铂医药干眼症新药特那西普2期研究结果即将公布，效果良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=131620350518)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410079, encodeId=6c9e14100e94a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=琅铧医药获发作性睡病治疗药物Wakix(pitolisant) 中国**权益, objectType=article, longId=203242, objectId=a3a220324236, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3a220324236, replyNumber=0, likeNumber=73, createdTime=2020-11-12, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3a220324236, moduleTitle=琅铧医药获发作性睡病治疗药物Wakix(pitolisant) 中国**权益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3a220324236)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410078, encodeId=69e214100e8ee, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=济南市卫健委主任马效恩：发扬优势守正创新，全力打造中医药强市, objectType=article, longId=203116, objectId=c3f720311646, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3f720311646, replyNumber=0, likeNumber=69, createdTime=2020-11-09, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3f720311646, moduleTitle=济南市卫健委主任马效恩：发扬优势守正创新，全力打造中医药强市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3f720311646)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410077, encodeId=b39614100e7b7, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=海南将开放创新发展中医药服务贸易建中医药现代产业体系, objectType=article, longId=202968, objectId=89bd202968d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89bd202968d6, replyNumber=0, likeNumber=80, createdTime=2020-11-07, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89bd202968d6, moduleTitle=海南将开放创新发展中医药服务贸易建中医药现代产业体系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89bd202968d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410076, encodeId=58f514100e6e7, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=世界流感日：专家谈中医药防治流感的价值, objectType=article, longId=202923, objectId=2fe2202923b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fe2202923b5, replyNumber=0, likeNumber=116, createdTime=2020-11-06, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fe2202923b5, moduleTitle=世界流感日：专家谈中医药防治流感的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fe2202923b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410075, encodeId=745b14100e50a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=医药代表备案制即将出台，追根朔源回归学术价值, objectType=article, longId=202915, objectId=df4b20291520, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df4b20291520, replyNumber=0, likeNumber=103, createdTime=2020-11-06, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df4b20291520, moduleTitle=医药代表备案制即将出台，追根朔源回归学术价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df4b20291520)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410074, encodeId=895714100e4d7, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=思路迪医药获得海和药物两款镇痛新药AAT-076和grapiprant在中国的**权利, objectType=article, longId=202570, objectId=c5582025e027, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5582025e027, replyNumber=0, likeNumber=57, createdTime=2020-10-30, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5582025e027, moduleTitle=思路迪医药获得海和药物两款镇痛新药AAT-076和grapiprant在中国的**权利, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5582025e027)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410073, encodeId=950214100e36e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=国内国际“双循环”开创中医药发展新格局 ——第十六届国际络病学大会暨第八届中西医结合血管病学大会盛大召开, objectType=article, longId=202458, objectId=b8f22024588e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8f22024588e, replyNumber=0, likeNumber=64, createdTime=2020-10-26, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8f22024588e, moduleTitle=国内国际“双循环”开创中医药发展新格局 ——第十六届国际络病学大会暨第八届中西医结合血管病学大会盛大召开, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8f22024588e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410072, encodeId=980a14100e2bf, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=14款仿制药通过一致性评价，来自正大天晴、福元医药…, objectType=article, longId=202329, objectId=d9f92023292c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9f92023292c, replyNumber=0, likeNumber=120, createdTime=2020-10-22, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9f92023292c, moduleTitle=14款仿制药通过一致性评价，来自正大天晴、福元医药…, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9f92023292c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410071, encodeId=12ba14100e1f3, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=亚盛医药两款靶向凋亡的新药，获得FDA的孤儿药指定, objectType=article, longId=201944, objectId=1c9620194495, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c9620194495, replyNumber=0, likeNumber=62, createdTime=2020-10-12, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c9620194495, moduleTitle=亚盛医药两款靶向凋亡的新药，获得FDA的孤儿药指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c9620194495)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410070, encodeId=294814100e054, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=亚盛医药细胞凋亡抑制剂再获2项FDA孤儿药认证, objectType=article, longId=201868, objectId=511920186833, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=511920186833, replyNumber=0, likeNumber=72, createdTime=2020-10-11, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=511920186833, moduleTitle=亚盛医药细胞凋亡抑制剂再获2项FDA孤儿药认证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=511920186833)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410069, encodeId=1ec614100690f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=“十四五”卫生发展规划九大关键词：国家医学中心、区域医疗中心、县域医共体、互联网+医疗、中医药传承……, objectType=article, longId=201864, objectId=3faa20186486, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3faa20186486, replyNumber=0, likeNumber=58, createdTime=2020-10-11, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3faa20186486, moduleTitle=“十四五”卫生发展规划九大关键词：国家医学中心、区域医疗中心、县域医共体、互联网+医疗、中医药传承……, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3faa20186486)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410068, encodeId=407d1410068a0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=恒瑞医药正在瑞士巴塞尔建立欧洲临床研发中心, objectType=article, longId=201859, objectId=60cd2018593c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60cd2018593c, replyNumber=0, likeNumber=62, createdTime=2020-10-10, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60cd2018593c, moduleTitle=恒瑞医药正在瑞士巴塞尔建立欧洲临床研发中心, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60cd2018593c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410067, encodeId=5dd0141006e98, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=《医药代表备案管理办法（试行）》，不得统方! 不得卖药! 不得提供赞助!, objectType=article, longId=201424, objectId=6f18201424e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f18201424e6, replyNumber=0, likeNumber=62, createdTime=2020-10-02, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f18201424e6, moduleTitle=《医药代表备案管理办法（试行）》，不得统方! 不得卖药! 不得提供赞助!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f18201424e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410066, encodeId=66261410066d7, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=中国医药创新与投资大会在苏召开，医药产业新格局显现, objectType=article, longId=201301, objectId=94f320130140, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94f320130140, replyNumber=0, likeNumber=73, createdTime=2020-09-29, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94f320130140, moduleTitle=中国医药创新与投资大会在苏召开，医药产业新格局显现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94f320130140)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410065, encodeId=57e0141006560, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=曙方医药与Minoryx达成神经系统罕见病新药Leriglitazone在中国内地、香港及澳门的**授权协议, objectType=article, longId=201120, objectId=e8f320112070, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8f320112070, replyNumber=0, likeNumber=66, createdTime=2020-09-25, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8f320112070, moduleTitle=曙方医药与Minoryx达成神经系统罕见病新药Leriglitazone在中国内地、香港及澳门的**授权协议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8f320112070)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

医药

2020-05-29

cathymary (审核中...)

前往app查看评论内容

#医药#

今日，医药代表备案制正式施行

2020-12-04

cathymary (审核中...)

前往app查看评论内容

#医药#

殊途同归——中日医药代表新规比较

2020-12-04

cathymary (审核中...)

前往app查看评论内容

#医药#

北京市中医药条例通过禁止虚假、夸大宣传中医药

2020-12-03

cathymary (审核中...)

前往app查看评论内容

#医药#

中国生物医药黄金时代已来，学术转化困境犹存

2020-11-30

cathymary (审核中...)

前往app查看评论内容

#医药#

和铂医药干眼症新药特那西普2期研究结果即将公布，效果良好

2020-11-19

cathymary (审核中...)

前往app查看评论内容

#医药#

琅铧医药获发作性睡病治疗药物Wakix(pitolisant) 中国**权益

2020-11-12

cathymary (审核中...)

前往app查看评论内容

#医药#

济南市卫健委主任马效恩：发扬优势守正创新，全力打造中医药强市

2020-11-09

cathymary (审核中...)

前往app查看评论内容

#医药#

海南将开放创新发展中医药服务贸易建中医药现代产业体系

2020-11-07

cathymary (审核中...)

前往app查看评论内容

#医药#

世界流感日：专家谈中医药防治流感的价值

2020-11-06

cathymary (审核中...)

前往app查看评论内容

#医药#

医药代表备案制即将出台，追根朔源回归学术价值

2020-11-06

cathymary (审核中...)

前往app查看评论内容

#医药#

思路迪医药获得海和药物两款镇痛新药AAT-076和grapiprant在中国的**权利

2020-10-30

cathymary (审核中...)

前往app查看评论内容

#医药#

国内国际“双循环”开创中医药发展新格局 ——第十六届国际络病学大会暨第八届中西医结合血管病学大会盛大召开

2020-10-26

cathymary (审核中...)

前往app查看评论内容

#医药#

14款仿制药通过一致性评价，来自正大天晴、福元医药…

2020-10-22

cathymary (审核中...)

前往app查看评论内容

#医药#

亚盛医药两款靶向凋亡的新药，获得FDA的孤儿药指定

2020-10-12

cathymary (审核中...)

前往app查看评论内容

#医药#

亚盛医药细胞凋亡抑制剂再获2项FDA孤儿药认证

2020-10-11

cathymary (审核中...)

前往app查看评论内容

#医药#

“十四五”卫生发展规划九大关键词：国家医学中心、区域医疗中心、县域医共体、互联网+医疗、中医药传承……

2020-10-11

cathymary (审核中...)

前往app查看评论内容

#医药#

恒瑞医药正在瑞士巴塞尔建立欧洲临床研发中心

2020-10-10

cathymary (审核中...)

前往app查看评论内容

#医药#

《医药代表备案管理办法（试行）》，不得统方! 不得卖药! 不得提供赞助!

2020-10-02

cathymary (审核中...)

前往app查看评论内容

#医药#

中国医药创新与投资大会在苏召开，医药产业新格局显现

2020-09-29

cathymary (审核中...)

前往app查看评论内容

#医药#

曙方医药与Minoryx达成神经系统罕见病新药Leriglitazone在中国内地、香港及澳门的**授权协议

2020-09-25

科室
- - 订阅+
  - 更多科室
工具
服务